These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32558178)

  • 1. The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction.
    Noble SM; Ahern AM; Worthington J; Hashim H; Taylor H; Young GJ; Brookes S; Abrams P; Johnson L; Khan R; Page T; Swami KS; Lane JA
    BJU Int; 2020 Nov; 126(5):595-603. PubMed ID: 32558178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT.
    Worthington J; Lane JA; Taylor H; Young G; Noble SM; Abrams P; Ahern A; Brookes ST; Cotterill N; Johnson L; Khan R; Fernandez AM; Page T; Swami S; Hashim H
    Health Technol Assess; 2020 Sep; 24(41):1-96. PubMed ID: 32901611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial to determine the clinical and cost effectiveness of thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP) in the National Health Service (NHS) - the UNBLOCS trial: a study protocol for a randomised controlled trial.
    Worthington J; Taylor H; Abrams P; Brookes ST; Cotterill N; Noble SM; Page T; Swami KS; Lane JA; Hashim H
    Trials; 2017 Apr; 18(1):179. PubMed ID: 28412960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial.
    Hashim H; Worthington J; Abrams P; Young G; Taylor H; Noble SM; Brookes ST; Cotterill N; Page T; Swami KS; Lane JA;
    Lancet; 2020 Jul; 396(10243):50-61. PubMed ID: 32622397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis.
    Deng Z; Sun M; Zhu Y; Zhuo J; Zhao F; Xia S; Han B; Herrmann TRW
    World J Urol; 2018 Sep; 36(9):1355-1364. PubMed ID: 29651642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on: Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT.
    Bozzini G; Berti L; Maltagliati M; Becker B; Herrmann TRW; Sighinolfi MC; Buizza C; Rocco B
    World J Urol; 2022 Feb; 40(2):615-616. PubMed ID: 33386493
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic Value of the Transurethral Resection in Saline System for Treatment of Benign Prostatic Hyperplasia in England and Wales: Systematic Review, Meta-analysis, and Cost-Consequence Model.
    Treharne C; Crowe L; Booth D; Ihara Z
    Eur Urol Focus; 2018 Mar; 4(2):270-279. PubMed ID: 28753756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thulium (Tm:YAG) laser vaporesection of prostate and bipolar transurethral resection of prostate in patients with benign prostate hyperplasia: a systematic review and meta-analysis.
    Lan Y; Wu W; Liu L; Zhou S; Lan C; Ketegwe IR; Zeng G
    Lasers Med Sci; 2018 Sep; 33(7):1411-1421. PubMed ID: 29947009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective.
    Caicedo JI; Taborda A; Robledo D; Bravo-Balado A; Domínguez C; Trujillo CG; Cataño JG; Campos Hernández J; Londoño Trujillo D; Plata M
    World J Urol; 2019 May; 37(5):861-866. PubMed ID: 30116964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis.
    Erman A; Masucci L; Krahn MD; Elterman DS
    BJU Int; 2018 Nov; 122(5):879-888. PubMed ID: 30113127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia.
    Fowler C; McAllister W; Plail R; Karim O; Yang Q
    Health Technol Assess; 2005 Feb; 9(4):iii-iv, 1-30. PubMed ID: 15698525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Analytical Comparison of Short-term Effectiveness and Safety Between Thulium:YAG Laser Vaporesection of the Prostate and Bipolar Transurethral Resection of the Prostate in Patients With Benign Prostatic Hyperplasia.
    Kim JW; Kim YJ; Lee YH; Kwon JB; Cho SR; Kim JS
    Korean J Urol; 2014 Jan; 55(1):41-6. PubMed ID: 24466396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral prostate resection, noncontact laser therapy or conservative management in men with symptoms of benign prostatic enlargement? An economic evaluation.
    Noble SM; Coast J; Brookes S; Neal DE; Abrams P; Peters TJ; Donovan JL
    J Urol; 2002 Dec; 168(6):2476-82. PubMed ID: 12441944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of Emergency Room Visits for Bleeding Complications Following Transurethral Procedures in the Treatment of Benign Prostatic Hyperplasia: A Retrospective Cohort Study.
    Teng TC; Shao IH; Hsu YC; Chen Y; Tsao SH; Kang YT; Hsieh ML
    Clin Interv Aging; 2021; 16():1747-1756. PubMed ID: 34616148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of transurethral enucleation of the prostate using the 120-W thulium Laser (Vela™ XL) compared to bipolar transurethral resection of the prostate (TURP) in aging male.
    Hou CP; Lin YH; Juang HH; Chang PL; Chen CL; Yang PS; Tsui KH
    Aging (Albany NY); 2020 Jan; 12(2):1888-1898. PubMed ID: 31991402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
    Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
    J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.